FOXP1 expression correlates with better prognosis in invasive breast cancer including the ER-positive luminal subtypeTools Joseph, C. and Craze, Madeleine L. and Nolan, C.C. and Diez-Rodriguez, Maria and Green, Andrew R. and Rakha, Emad and Ellis, Ian O. and Mukherjee, A. (2017) FOXP1 expression correlates with better prognosis in invasive breast cancer including the ER-positive luminal subtype. In: Belfast Pathology 2017: 10th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 20-23 June 2017, Belfast , United Kingdom.
Official URL: https://www.path.org.uk/wp-content/uploads/2017/06/BP2017-PLENARY-ORAL-ABSTRACTS-05.06.17.pdf
AbstractBackground: Fork head box P1 (FOXP1) is a FOX family transcription factor influencing ERα;-regulated transcription by interaction with the ERα; related pioneer factor FOXA1. Altered FOXP1 expression is seen in breast and prostate cancers. This study investigated FOXP1 at the protein level in breast cancer (BC) and examined associations with clinicopathological and molecular features.
Actions (Archive Staff Only)
|